tiprankstipranks
Cyclo Therapeutics (CYTH)
NASDAQ:CYTH
US Market
Holding CYTH?
Track your performance easily

Cyclo Therapeutics (CYTH) Ownership - Who Owns Cyclo Therapeutics?

198 Followers

Cyclo Therapeutics (CYTH) Ownership Overview

54.01%2.67%4.66%2.25%36.40%
54.01% Insiders
4.66% Other Institutional Investors
2.25% ETFs
36.40% Public Companies and
Individual Investors
The ownership structure of Cyclo Therapeutics (CYTH) stock is a mix of institutional, retail, and individual investors. Approximately 9.58% of the company’s stock is owned by Institutional Investors, 54.01% is owned by Insiders, and 36.40% is owned by Public Companies and Individual Investors.
The ownership structure of Cyclo Therapeutics (CYTH) stock is a mix of institutional, retail, and individual investors. Approximately 7.33% of the company’s stock is owned by Institutional Investors, 54.01% is owned by Insiders, and 2.25% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
12,998,194Insider45.43%8,838,772
743,804Insider2.60%505,787
598,694Institution2.09%407,112
598,694Institution2.09%407,112
382,122Insider1.34%259,843
369,103Insider1.29%250,990
348,771Insider1.22%237,164
165,296Institution0.58%112,401
148,826Insider0.52%101,202
145,826Insider0.51%99,162

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
598,694Institution2.09%407,112
165,296Institution0.58%112,401
623Institution<0.01%424

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
437,611Institution1.53%290,661
161,083Institution0.56%106,991
44,819Institution0.16%30,746

FAQ

Who Owns Cyclo Therapeutics (CYTH)?
According to the latest TipRanks data, approximately 4.66% of the company's stock is held by institutional investors, 54.01% is held by insiders, and 36.40% is held by retail investors.
    What percentage of Cyclo Therapeutics (CYTH) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 4.66% of Cyclo Therapeutics (CYTH) stock is held by institutional investors.
      What percentage of Cyclo Therapeutics (CYTH) stock is held by retail investors?
      According to the latest TipRanks data, approximately 36.40% of Cyclo Therapeutics (CYTH) stock is held by retail investors.
        Who owns the most shares of Cyclo Therapeutics (CYTH)?
        Rafael Holdings, Inc. owns the most shares of Cyclo Therapeutics (CYTH).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis